Pharmaceutical Executive-03-01-2016

Pharmaceutical Executive

Data Disclosure: Sealing the Error Envelope

March 07, 2016

From the Editor

36

3

With the emerging industry commitment to publicly disclose research and clinical trial results, two pivotal issues come to mind - and serve as a reminder to companies that true transparency depends on the truthfulness of the evidence that binds it.

Vaccines 2016: Big Bets for Global Threats

March 07, 2016

Features

36

3

A new wave of technologies supported by innovative business models is transforming the vaccine landscape - and raising the bar on performance. As the demand for cures for chronic diseases accelerates, and with more global outbreaks of viral diseases like Zika and Ebola a virtual certainty, solutions can’t come soon enough.

Country Report: The Netherlands

March 01, 2016

Special Sponsored Section

36

3

The Dutch healthcare system, dubbed today as a “laboratory for change,” is in the midst of reinventing itself around collaborations with industry and government in such areas as market and patient access, transparency, cost-effectiveness, and process innovation.

Pharmaceutical Executive, March 2016 Issue (PDF)

March 01, 2016

Issue PDF

36

3

Click the title above to open the Pharmaceutical Executive March 2016 issue in an interactive PDF format.